AstraZeneca PLC year-to-date and Q3 Results 2015

Tomorrow, Thursday, 5th November 2015, AstraZeneca PLC will release year-to-date and Q3 results for 2015 at 07:00 GMT.

An analyst presentation of the year to date and Q3 results for 2015 will take place at 12:00 GMT and will be accessible by a choice of two routes:

Audio webcast

The presentation will be available to download on the AstraZeneca Investor Relations website two hours before the analyst presentation begins.

Teleconference with Q&A
.  Dial in numbers:

UK (freephone): 0800 694 2370
International: +44 (0) 1452 557 749
Sweden (freephone): 0200 883 079
US (freephone): 866 977 7645

Conference ID:  75218823

Details of the teleconference and webcast replay facilities are available on the Investor Relations section of the AstraZeneca website



About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit:


Documents & Links